U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620158) titled 'Proof of Concept Study to Isolate Cosmetic Improvement of Skin Using the Vitro Biopharma Secretome/Exosome Serum' on May 13.
Brief Summary: The purpose of this research is to characterize the safety, tolerability and efficacy of the investigational topical cosmetic product, the Vitro Biopharma Exosome Serum (Intervention), in impacting the cosmetic appearance of skin along with a microneedling procedure.
Study Start Date: April 17, 2024
Study Type: INTERVENTIONAL
Condition:
Cosmetic Effect
Intervention:
OTHER: Secretome/Exosome Serum
The Vitro Biopharma Exosome Serum contains extracellular vesicles derived from umbilical cord ...